ADHD Medication and Pregnancy
GPs may prescribe stimulants to treat ADHD (methylphenidate dexamfetamine, methylphenidate, and lisdexamfetamine), as well as non-stimulants like modafinil and atomoxetine. These medications can help patients manage their ADHD symptoms and make regular appointments with an GP or a specialist.
The majority of studies on the safety of ADHD medication during pregnancy limit the results to live births. This undervalues the severe adverse teratogenic effects that can cause terminations and abortions. This is the first study to include these data.
Risk/Benefit Discussion
Many women with ADHD face a dilemma when they are taking stimulants during pregnancy. On the one side, many women suffering from ADHD function well when they are taking their medication. If they stop, it could result in marital conflict, problems at work or school, and other serious consequences. On the other hand they do not want to expose their unborn baby to medications whose long-term effects are not known.
Some doctors suggest to their patients to stop taking ADHD medications prior to having a baby, but others have found a balance between the assumption of safety and individual patient needs. These patients often consult their physicians and/or spouses before making the decision. They strike the right balance between the mother's need to take her medication and the potential for serious symptoms, like agitation and depression, when she stops taking the medication.
The majority of studies on ADHD medication and pregnancy concentrate on the effects of first-trimester exposure to stimulant medications on the formation of abnormalities in the fetus (eg cardiac malformations). However, the current literature is inconclusive. The literature is inconsistent, in part because most studies do not provide information on other outcomes than live births (eg. terminations, miscarriages and stillbirths), nor do they take into account confounding variables such as pregnancy characteristics, calendar year and sociodemographics of the mother.
The results of some studies indicate that there is no risk to the fetus through the use of stimulant medications before, during, or after the first trimester. The signals for certain cardiac abnormalities are clear. This is particularly relevant for VSD (ventricular defect). However these findings need to be confirmed in larger studies that provide more precise information.
There isn't enough evidence to establish a connection between maternal use of methylphenidate (MPH) and Atomoxetine (ATO) and a greater incidence of gastroschisis, omphalocele, and transverse limb deficiency. These birth defects could be caused by other medications, however the risks are not clear due to the limited data available.
over the counter adhd medication to Beware of
Women with ADHD who are pregnant often face a difficult choice to make: Should they continue taking their ADHD medication or stop it? This is a major change in the life of both the mother and fetus. Many physicians feel that the ideal time to discuss this topic is when a patient informs her physician of her desire to have a baby, so that she has the information she requires to make a decision prior to becoming pregnant. However, this is not always possible and women often discover that they are pregnant at a later time in the pregnancy when it may be too late to stop taking medication.
There are a few studies on the safety of stimulants in pregnancy and breastfeeding. Most studies have been built on retrospective analyses of data that do not adequately control for factors such as maternal age at first exposure to the drug and chronic conditions, the stimulants' effects, co-treatment with psychiatric or pain medications as well as other factors that influence risk. how does medication for adhd work have demonstrated an increase in the risk of preeclampsia and premature birth when psychostimulants are administered during pregnancy. However these findings must be interpreted cautiously.
A few behavioral problems in infants are caused by the use of stimulants during pregnancy. Most commonly, tics (abnormal muscle movements) are reported in children. Other behavioral issues that have been noted include increased aggression, irritability and resentment. The good news is these symptoms usually improve once the medication is taken off.
Certain medications prescribed for ADHD are incompatible with other drugs and can trigger dangerous side effects when they are combined, especially with alcohol or other CNS stimulants (methylphenidate, amphetamine salts). These medications should not be combined together with narcotics or antidepressants, including pain relievers. They should be avoided by people who are using illicit drugs or nicotine products.
Some patients find that a reduction or discontinuation of ADHD medications during pregnancy is feasible without significant impairment to function. In these cases it is essential to inform the patient and her spouse or partner about this decision and to ask them for help in minimizing symptom recurrence. This may include identifying local resources, seeking help from friends or family or seeking accommodations in the workplace that can address symptoms-related impairments. It is also helpful to know more about effective cognitive-behavioral treatment and coaching for ADHD that can be offered by certified professionals.
Considerations for Medications
Both patients and doctors have a difficult time deciding whether or not to continue taking ADHD medication during pregnancy. It's a tough decision for patients suffering from co-occurring disorders as many of the drugs they use to treat their addictions share similar effects to standard ADHD medications. These include the possibility of high blood pressure or chest pain attacks.
Unfortunately, there aren't many options for those with these conditions and their doctors. Lack of research on how to safely treat a person suffering from ADHD and substance use disorder can lead some doctors to err on the side of caution and suggest that patients stop taking their medications during pregnancy.
Ideally, the issue of whether to continue taking ADHD medication is discussed before planning the birth of a child. Many women with ADHD are surprised to learn that they are pregnant. This is usually in the first trimester, when the development of the fetus is susceptible to exposure to drugs.
If the patient and doctor decide to continue with medication during the first trimester, they should pick the lowest dose possible and closely monitor symptoms. The doctor may also suggest that the woman supplement her dose with an immediate-release medication that is taken at the midpoint of the day, which will help to reduce the fluctuations and downs that are caused by the fluctuating levels of medication in the bloodstream.
In the near future, it is hoped that more research will be done on the best way to manage both ADHD and addiction disorders in those who are pregnant or breastfeeding. In the meantime women who are expecting or are planning to become pregnant should talk to their GP about what options they might have, including psychotherapy that focuses on ADHD symptoms and how this might differ from a medication only approach. If they choose not to take medication for ADHD, it is likely that they will face more challenges at work, school and even maintaining a relationship. This will likely affect their children, too.
Incorporate the use of Medications
Women who suffer from ADHD might take medications to manage symptoms such as inattention hyperactivity, and impulsivity. Recent studies have shown that these medications do not harm the fetus and are able to be used during pregnancy.
This is a good thing for women who want to become mothers and rely on their ADHD medication. Many women are worried that they should not continue taking their medications during pregnancy, particularly if they take stimulant medications like amphetamines and methylphenidate. These women should talk to their healthcare professionals about the potential risks and benefits associated with the use of medications according to current research and guidelines.
Methylphenidate is one of the most frequently prescribed ADHD medications and has been shown to be safe for women who are pregnant when under the supervision of a medical professional. Other stimulant medications that are commonly prescribed such as amphetamine and atomoxetine are also considered safe for women who are pregnant. It is important to remember that stimulants and other drugs should be closely monitored in pregnancy.
A recent study of data from Danish national registers showed that children born to mothers who took ADHD medication during their pregnancy had no adverse effect on the child's neurodevelopment or growth. These findings are significant as they cover a wider range of patients than previous studies and take into account many confounding factors.
The results also show that the use ADHD medication during pregnancy does not increase the risk of developing maternal complications, such as anemia, iron deficiency or hyperemesis. These findings are a significant improvement in our understanding of how the use of ADHD medications during pregnancy can be safely managed by obstetricians and psychiatrists.
Women with ADHD must continue to follow their treatment plan and closely work with their healthcare provider throughout their pregnancy. This will help to ensure that symptoms are treated properly, allowing women to enjoy their pregnancy. For those who cannot or choose not to discontinue medication, there are various non-pharmacological treatments that can ease symptoms and promote overall well-being during pregnancy. These include: